Cargando…
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806246/ https://www.ncbi.nlm.nih.gov/pubmed/23835862 http://dx.doi.org/10.1038/leu.2013.208 |
| _version_ | 1782288355043573760 |
|---|---|
| author | Todisco, E Ciceri, F Oldani, E Boschini, C Micò, C VanLint, M T Donnini, I Patriarca, F Alessandrino, P E Bonifazi, F Arcese, W Barberi, W Marenco, P Terruzzi, E Cortelazzo, S Santarone, S Proia, A Corradini, P Tagliaferri, E Falcioni, S Irrera, G Dallanegra, L Castagna, L Santoro, A Camboni, A Sacchi, N Bosi, A Bacigalupo, A Rambaldi, A |
| author_facet | Todisco, E Ciceri, F Oldani, E Boschini, C Micò, C VanLint, M T Donnini, I Patriarca, F Alessandrino, P E Bonifazi, F Arcese, W Barberi, W Marenco, P Terruzzi, E Cortelazzo, S Santarone, S Proia, A Corradini, P Tagliaferri, E Falcioni, S Irrera, G Dallanegra, L Castagna, L Santoro, A Camboni, A Sacchi, N Bosi, A Bacigalupo, A Rambaldi, A |
| author_sort | Todisco, E |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3806246 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38062462013-10-23 The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo Todisco, E Ciceri, F Oldani, E Boschini, C Micò, C VanLint, M T Donnini, I Patriarca, F Alessandrino, P E Bonifazi, F Arcese, W Barberi, W Marenco, P Terruzzi, E Cortelazzo, S Santarone, S Proia, A Corradini, P Tagliaferri, E Falcioni, S Irrera, G Dallanegra, L Castagna, L Santoro, A Camboni, A Sacchi, N Bosi, A Bacigalupo, A Rambaldi, A Leukemia Letter to the Editor Nature Publishing Group 2013-10 2013-07-30 /pmc/articles/PMC3806246/ /pubmed/23835862 http://dx.doi.org/10.1038/leu.2013.208 Text en Copyright © 2013 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
| spellingShingle | Letter to the Editor Todisco, E Ciceri, F Oldani, E Boschini, C Micò, C VanLint, M T Donnini, I Patriarca, F Alessandrino, P E Bonifazi, F Arcese, W Barberi, W Marenco, P Terruzzi, E Cortelazzo, S Santarone, S Proia, A Corradini, P Tagliaferri, E Falcioni, S Irrera, G Dallanegra, L Castagna, L Santoro, A Camboni, A Sacchi, N Bosi, A Bacigalupo, A Rambaldi, A The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo |
| title | The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo |
| title_full | The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo |
| title_fullStr | The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo |
| title_full_unstemmed | The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo |
| title_short | The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo |
| title_sort | cibmtr score predicts survival of aml patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the gruppo italiano trapianto di midollo osseo |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806246/ https://www.ncbi.nlm.nih.gov/pubmed/23835862 http://dx.doi.org/10.1038/leu.2013.208 |
| work_keys_str_mv | AT todiscoe thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT cicerif thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT oldanie thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT boschinic thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT micoc thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT vanlintmt thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT donninii thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT patriarcaf thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT alessandrinope thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT bonifazif thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT arcesew thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT barberiw thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT marencop thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT terruzzie thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT cortelazzos thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT santarones thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT proiaa thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT corradinip thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT tagliaferrie thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT falcionis thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT irrerag thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT dallanegral thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT castagnal thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT santoroa thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT cambonia thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT sacchin thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT bosia thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT bacigalupoa thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT rambaldia thecibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT todiscoe cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT cicerif cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT oldanie cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT boschinic cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT micoc cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT vanlintmt cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT donninii cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT patriarcaf cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT alessandrinope cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT bonifazif cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT arcesew cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT barberiw cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT marencop cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT terruzzie cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT cortelazzos cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT santarones cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT proiaa cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT corradinip cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT tagliaferrie cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT falcionis cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT irrerag cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT dallanegral cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT castagnal cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT santoroa cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT cambonia cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT sacchin cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT bosia cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT bacigalupoa cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo AT rambaldia cibmtrscorepredictssurvivalofamlpatientsundergoingallogeneictransplantationwithactivediseaseafteramyeloablativeorreducedintensityconditioningaretrospectiveanalysisofthegruppoitalianotrapiantodimidolloosseo |